AU2023214201A1 - A coagulation mold, a kit and a method for preparing a coagulated blood mass - Google Patents
A coagulation mold, a kit and a method for preparing a coagulated blood mass Download PDFInfo
- Publication number
- AU2023214201A1 AU2023214201A1 AU2023214201A AU2023214201A AU2023214201A1 AU 2023214201 A1 AU2023214201 A1 AU 2023214201A1 AU 2023214201 A AU2023214201 A AU 2023214201A AU 2023214201 A AU2023214201 A AU 2023214201A AU 2023214201 A1 AU2023214201 A1 AU 2023214201A1
- Authority
- AU
- Australia
- Prior art keywords
- powder
- whole blood
- calcium gluconate
- particle
- coagulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 163
- 210000004369 blood Anatomy 0.000 title claims abstract description 163
- 230000015271 coagulation Effects 0.000 title claims abstract description 71
- 238000005345 coagulation Methods 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims abstract description 49
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims description 136
- 239000005995 Aluminium silicate Substances 0.000 claims description 78
- 235000012211 aluminium silicate Nutrition 0.000 claims description 78
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 77
- 229960004494 calcium gluconate Drugs 0.000 claims description 68
- 239000004227 calcium gluconate Substances 0.000 claims description 68
- 235000013927 calcium gluconate Nutrition 0.000 claims description 68
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 68
- 229940127219 anticoagulant drug Drugs 0.000 claims description 12
- 230000000630 rising effect Effects 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 27
- 239000003999 initiator Substances 0.000 abstract description 7
- 231100000444 skin lesion Toxicity 0.000 abstract description 3
- 206010040882 skin lesion Diseases 0.000 abstract description 3
- 206010061245 Internal injury Diseases 0.000 abstract description 2
- 208000004680 Rectal Fistula Diseases 0.000 abstract description 2
- 206010002156 anal fistula Diseases 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000000725 suspension Substances 0.000 abstract description 2
- 210000002435 tendon Anatomy 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108010074864 Factor XI Proteins 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006624 extrinsic pathway Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Manufacturing & Machinery (AREA)
- Botany (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL290122 | 2022-01-25 | ||
| IL290122A IL290122B2 (en) | 2022-01-25 | 2022-01-25 | Clotting template, kit and method for making a blood clot |
| PCT/IL2023/050083 WO2023144818A1 (en) | 2022-01-25 | 2023-01-25 | A coagulation mold, a kit and a method for preparing a coagulated blood mass |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2023214201A1 true AU2023214201A1 (en) | 2024-08-08 |
| AU2023214201A2 AU2023214201A2 (en) | 2024-08-15 |
Family
ID=85238983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023214201A Pending AU2023214201A1 (en) | 2022-01-25 | 2023-01-25 | A coagulation mold, a kit and a method for preparing a coagulated blood mass |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US12397018B2 (https=) |
| EP (1) | EP4447889A1 (https=) |
| JP (1) | JP2025504710A (https=) |
| KR (1) | KR20240144143A (https=) |
| CN (1) | CN118613239A (https=) |
| AU (1) | AU2023214201A1 (https=) |
| CA (1) | CA3242778A1 (https=) |
| IL (1) | IL290122B2 (https=) |
| MX (1) | MX2024009036A (https=) |
| WO (1) | WO2023144818A1 (https=) |
| ZA (1) | ZA202406452B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025243305A1 (en) | 2024-05-23 | 2025-11-27 | Reddress Ltd. | Controlled drug delivery |
| EP4686486A1 (en) * | 2024-07-30 | 2026-02-04 | Paul Hartmann AG | Gel composition comprising whole blood |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2381969T3 (en) * | 2009-01-27 | 2016-09-05 | Reddress Ltd | METHODS OF MAKING wound dressings AND A BANK wound dressings |
| IL254636A0 (en) | 2017-09-24 | 2017-11-30 | Reddress Ltd | System and method for preparing a wound dressing |
| IL257229B (en) | 2018-01-30 | 2022-07-01 | Reddress Ltd | Blood applicator for tissue treatment |
-
2022
- 2022-01-25 IL IL290122A patent/IL290122B2/en unknown
-
2023
- 2023-01-25 EP EP23705316.0A patent/EP4447889A1/en active Pending
- 2023-01-25 MX MX2024009036A patent/MX2024009036A/es unknown
- 2023-01-25 WO PCT/IL2023/050083 patent/WO2023144818A1/en not_active Ceased
- 2023-01-25 AU AU2023214201A patent/AU2023214201A1/en active Pending
- 2023-01-25 CN CN202380018300.XA patent/CN118613239A/zh active Pending
- 2023-01-25 CA CA3242778A patent/CA3242778A1/en active Pending
- 2023-01-25 JP JP2024539932A patent/JP2025504710A/ja active Pending
- 2023-01-25 KR KR1020247024731A patent/KR20240144143A/ko active Pending
-
2024
- 2024-07-24 US US18/783,156 patent/US12397018B2/en active Active
- 2024-08-22 ZA ZA2024/06452A patent/ZA202406452B/en unknown
- 2024-12-16 US US18/983,077 patent/US20250114399A1/en active Pending
-
2025
- 2025-01-21 US US19/032,762 patent/US12599629B2/en active Active
- 2025-02-20 US US19/058,528 patent/US12364713B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN118613239A (zh) | 2024-09-06 |
| EP4447889A1 (en) | 2024-10-23 |
| US12397018B2 (en) | 2025-08-26 |
| IL290122B2 (en) | 2023-08-01 |
| WO2023144818A1 (en) | 2023-08-03 |
| US20250161353A1 (en) | 2025-05-22 |
| AU2023214201A2 (en) | 2024-08-15 |
| MX2024009036A (es) | 2024-08-06 |
| US20250114399A1 (en) | 2025-04-10 |
| KR20240144143A (ko) | 2024-10-02 |
| IL290122B1 (en) | 2023-04-01 |
| US20240374636A1 (en) | 2024-11-14 |
| US20250186488A1 (en) | 2025-06-12 |
| IL290122A (https=) | 2022-03-01 |
| ZA202406452B (en) | 2025-04-30 |
| JP2025504710A (ja) | 2025-02-17 |
| US12364713B2 (en) | 2025-07-22 |
| US12599629B2 (en) | 2026-04-14 |
| CA3242778A1 (en) | 2023-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12364713B2 (en) | Coagulation mold, a kit and a method for preparing a coagulated blood mass | |
| FI114780B (fi) | Menetelmä pitkitetysti vapauttavien hiukkasten valmistamiseksi | |
| US8741980B2 (en) | Hardenable two part acrylic composition | |
| CN105705171B (zh) | 通过胶原蛋白和玻尿酸的天然交联强化其橡胶性质物性的生体材料物质及其制造方法和使用方法 | |
| JP2016531602A (ja) | 硬化性マルチパートアクリル組成物 | |
| EP0166263A1 (en) | Filler composition for filling in defect or hollow portion of bone and kit or set for the preparation of the filler composition | |
| RU2228118C2 (ru) | Мясной рубленый полуфабрикат и способ его производства | |
| FR2638357A1 (fr) | Composition pharmaceutique comprenant du piroxicam et son procede de preparation | |
| DE4006145C2 (https=) | ||
| JP2006522782A (ja) | 植込剤の新規製造方法 | |
| JPS60192563A (ja) | 木綿豆腐様豆腐の製造法 | |
| JPS62265958A (ja) | 豆腐の製造方法 | |
| WO2017090536A1 (ja) | 豆腐こんにゃくの製造方法 | |
| JPS6087753A (ja) | カルシウム強化豆腐の製造法 | |
| CA2111697C (en) | A process for producing suppositories by compression and suppositories obtained by the process | |
| JP2005111130A (ja) | 骨補填材の製造方法 | |
| WO2025122687A1 (en) | Polymeric ion releasing fillers | |
| JP2023177517A (ja) | 速崩壊性圧縮成形物の製造方法および速崩壊性圧縮成形物 | |
| JPH08336368A (ja) | 豆腐の凝固方法 | |
| JP2003219830A (ja) | 胡麻入り豆腐及びその製造方法 | |
| EP1386894A1 (en) | Kneaded product containing calcium phosphate cement and method for preparation thereof | |
| JPH0965845A (ja) | 豆腐の凝固成型方法及び装置 | |
| JP2002291863A (ja) | 生体用リン酸カルシウム骨充填セメント練和物及びその製造方法 | |
| JPH0643295B2 (ja) | 錠剤の製造方法 | |
| CN104337806A (zh) | 一种维生素c注射液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT FILED 19 JUL 2024 |